Changes after publication

Changes after publication

May 2014: minor maintenance

February 2014: implementation section updated to clarify that dronedarone is recommended as an option for treating non-permanent atrial fibrillation. Additional minor maintenance update also carried out.

December 2012: recommendation 1.1 amended to reflect the change in the dronedarone marketing authorisation.

October 2012: a note has been added explaining the review decision for this guidance and the change in the dronedarone marketing authorisation.

March 2012: minor maintenance

  • National Institute for Health and Care Excellence (NICE)